PREVAC Study Team; Mark Kieh, Laura Richert, Abdoul H Beavogui, Birgit Grund, Bailah Leigh, Eric D'Ortenzio, Seydou Doumbia, Edouard Lhomme, Samba Sow, Renaud Vatrinet, Céline Roy, Stephen B Kennedy, Sylvain Faye, Shelley Lees, Niouma P Millimouno, Alseny M Camara, Mohamed Samai, Gibrilla F Deen, Moussa Doumbia, Hélène Espérou, Jerome Pierson, Deborah Watson-Jones, Alpha Diallo, Deborah Wentworth, Chelsea McLean, Jakub Simon, Aurélie Wiedemann, Bonnie Dighero-Kemp, Lisa Hensley, H Clifford Lane, Yves Levy, Peter Piot, Brian Greenwood, Geneviève Chêne, James Neaton, Yazdan Yazdanpanah. Randomized Trial of Vaccines for Zaire Ebola Virus Disease. 2022. The New England Journal of Medicine. 387. 2411-2424.
Chételat G, Lutz A, Klimecki O, Frison E, Asselineau J, Schlosser M, Arenaza-Urquijo EM, Mézenge F, Kuhn E, Moulinet I, Touron E, Dautricourt S, André C, Palix C, Ourry V, Felisatti F, Gonneaud J, Landeau B, Rauchs G, Chocat A, Quillard A, Devouge EF, Vuilleumier P, de La Sayette V, Vivien D, Collette F, Poisnel G, Marchant N ; the Medit-Ageing Research Group. Effect of an 18-Month Meditation Training on Regional Brain Volume and Perfusion in Older Adults: The Age-Well Randomized Clinical Trial. 2022. JAMA Neurology. 79. 1165-1174.
Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, Rémi Sitta, Ambre Gelley, Julie Chastang, Lionel Piroth, Christine Binquet, Julie Dupouy, Alain Makinson , Benjamin Lefèvre, Jean-Marc Naccache, Caroline Roussillon, Roland Landman, Cédrick Wallet, Sophie Karcher, Valérie Journot, Duc Nguyen, Thierry Pistone, Stéphane Bouchet, Marie-Edith Lafon, Mathieu Molimard, Rodolphe Thiébaut, Xavier de Lamballerie, Jean-Philippe Joseph, Laura Richert, Olivier Saint-Lary, Sarah Djabarouti, Linda Wittkop, Xavier Anglaret, Denis Malvy ; Coverage Study Group. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE). 2022. Clinical Microbiology and Infection. 28. 00108-2.
Zacchaeus Anywaine, Houreratou Barry, Omu Anzala, Gaudensia Mutua, Sodiomon B. Sirima, Serge Eholie, Hannah Kibuuka, Christine Bétard, Laura Richert, Christine Lacabaratz, M. Juliana McElrath, Stephen C. De Rosa, Kristen W. Cohen, Georgi Shukarev, Michael Katwere, Cynthia Robinson,Auguste Gaddah, Dirk Heerwegh, Viki Bockstal, Kerstin Luhn, Maarten Leyssen, Rodolphe Thiébaut , Macaya Douoguih ; EBL2002 Study group. Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial. 2022. PLOS Medicine. 19. e1003865.
Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka, Zacchaeus Anywaine, Sodiomon B. Sirima, Nicolas Meda, Omu Anzala, Serge Eholie, Christine Bétard, Laura Richert, Christine Lacabaratz, M. Juliana McElrath, Stephen De Rosa, Kristen W. Cohen, Georgi Shukarev, Cynthia Robinson, Auguste Gaddah, Dirk Heerwegh, Viki Bockstal, Kerstin Luhn, Maarten Leyssen, Macaya Douoguih , Rodolphe Thiébaut ; the EBL2002 Study group. Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa. 2021. PLOS Medicine. 18. e1003813.
Moses Badio, Edouard Lhomme, Mark Kieh, Abdoul Habib Beavogui, Stephen B. Kennedy, Seydou Doumbia, Bailah Leigh, Samba O. Sow, Alpha Diallo, Daniela Fusco, Matthew Kirchoff, Monique Termote, Renaud Vatrinet, Deborah Wentworth, Helène Esperou, H. Clifford Lane, Jerome Pierson, Deborah Watson-Jones, Céline Roy, Eric D’Ortenzio, Brian Greenwood, Genevieve Chêne, Laura Richert, James D. Neaton, the PREVAC study team. Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries. 2021. Trials. 22. 583.
Helen R. Wagstaffe, Giada Susannini, Rodolphe Thiébaut, Laura Richert, Yves Lévy, Viki Bockstal, Jeroen N. Stoop, Kerstin Luhn, Macaya Douoguih, Eleanor M. Riley, Christine Lacabaratz & Martin R. Goodier. Durable natural killer cell responses after heterologous two-dose Ebola vaccination. 2021. NPJ Vaccines. 6. 19.
Antoine Italiano, Derek Dinart, Isabelle Soubeyran, Carine Bellera, Hélène Espérou, Christelle Delmas, Noémie Mercier, Sabrina Albert, Ludivine Poignie, Anne Boland, Aurélien Bourdon, Damien Geneste, Quentin Cavaille, Yec’han Laizet, Emmanuel Khalifa, Céline Auzanneau, Barbara Squiban, Nathalène Truffaux, Robert Olaso, Zuzana Gerber, Cédrick Wallet, Antoine Bénard, Jean-Yves Blay, Pierre Laurent-Puig, Jean-François Deleuze, Carlo Lucchesi, Simone Mathoulin-Pelissier & the MULTISARC study group. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial. 2021. BMC Cancer. 21. 1180.
Natalie L. Marchant Corresponding Author, Thorsten Barnhofer, Roxane Coueron, Miranka Wirth, Antoine Lutz, Eider M. Arenaza-Urquijo, Fabienne Collette, Géraldine Poisnel, Harriet Demnitz-King, Ann-Katrin Schild, Nina Coll-Padros, Floriane Delphin-Combe, Tim Whitfield, Marco Schlosser; Julie Gonneaud, Julien Asselineau, Zuzana Walker, Pierre Krolak-Salmon, José Luis Molinuevo, Eric Frison, Gael Chételat, Frank Jessen, Olga M. Klimecki, The Medit-Ageing Research Group. Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial. 2021. Psychotherapy and Psychosomatics. 90. 341-350.
